Reimbursement authority NICE published draft guidance today giving a green light to the use of Columvi (glofitamab) in ...

The use of hair straighteners and chemical relaxers may be associated with a higher incidence of pancreatic cancer, thyroid cancer, and non-Hodgkin’s lymphoma, according to a study.

The survival rate of frozen eggs and embryos reaches more than 90% in good in vitro fertilization labs when a patient is ...

New data from cohort 3 show EO2463 can be safely added to rituximab in first-line low-tumor-burden follicular lymphoma in need of treatment; All six patients responded positively ...

Cancer treatment drug Pembroria, which has the same active ingredient as Keytruda but is cheaper, has been licensed for ...

Preexisting autoimmune diseases are tied to shorter hospital stays and less toxicity risk in patients receiving chimeric ...

ANTLER phase 1 data demonstrate efficacy and durability on par with autologous CAR-T cell therapy and safety allows for ...

Scientists have uncovered a new environmental culprit behind liver disease: tetrachloroethylene (PCE), a chemical used in dry ...

Geertsen would spend four full seasons with the Colorado Avalanche’s AHL affiliates spanning the San Antonio Rampage and ...

The drug given every three weeks via an intravenous infusion will be available from today thanks to the NHS fast-tracking access through its Cancer Drugs Fund, which provides patients with quicker ...

Q3 2025 Earnings Call Transcript November 12, 2025 CorMedix Inc. beats earnings expectations. Reported EPS is $1259.23, ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced its business update and financial results for the first nine months of 2025. "This quarter highlights ...